‘’An important part of our growth strategy is to increase our presence in Asia Pacific and emerging markets’’ Read more
TauRx Therapeutics initiates two global Phase III clinical trials in mild to moderate Alzheimer’s disease Read more
Novartis to construct biotechnology facility in Singapore with an investment of over $500 million Read more